← back to search

Alexandr V. Bazhin

Deutschen Konsortium für Translationale Krebsforschung · DE
Area of research
Immunology · Oncology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Immune cells in cancer, Immunotherapy and Immune Responses, and Immune Cell Function and Interaction.
h-index
32
citations
4,598
works
87
NIH funding
primary concept
email

Recent publications

Gut Barrier Dysfunction and Bacterial Lipopolysaccharides in Colorectal Cancer
Journal of Gastrointestinal Surgery 2023cited by 57position: middledoi
CD96 as a Potential Immune Regulator in Cancers
International Journal of Molecular Sciences 2023cited by 31position: lastdoi
Molecular characteristics of microsatellite stable early-onset colorectal cancer as predictors of prognosis and immunotherapeutic response
npj Precision Oncology 2023cited by 24position: middledoi
Tigecycline causes loss of cell viability mediated by mitochondrial OXPHOS and RAC1 in hepatocellular carcinoma cells
Journal of Translational Medicine 2023cited by 19position: middledoi
In-vitro model to mimic T cell subset change in human PDAC organoid co-culture
Journal of Cancer Research and Clinical Oncology 2023cited by 13position: middledoi
Smoking as a risk factor for colorectal neoplasms in young individuals? A systematic meta-analysis
International Journal of Colorectal Disease 2023cited by 12position: middledoi
Dynamics of Peripheral Blood Immune Cells during the Perioperative Period after Digestive System Resections: A Systematic Analysis of the Literature
Journal of Clinical Medicine 2023cited by 6position: lastdoi
SPOCK2 gene expression is downregulated in pancreatic ductal adenocarcinoma cells and correlates with prognosis of patients with pancreatic cancer
Journal of Cancer Research and Clinical Oncology 2023cited by 6position: lastdoi
Effect of Surgery on Postoperative Levels of the Gut Homeostasis-Regulating Enzyme Intestinal Alkaline Phosphatase
Journal of the American College of Surgeons 2023cited by 2position: middledoi
Myeloid-Derived Suppressor Cells in Solid Tumors
Cells 2022cited by 106position: lastdoi
Analysis of Circulating Immune Subsets in Primary Colorectal Cancer
Cancers 2022cited by 9position: middledoi
mRNA-Based Cancer Vaccines: A Therapeutic Strategy for the Treatment of Melanoma Patients
Vaccines 2021cited by 97position: middledoi
The Advantages and Challenges of Anticancer Dendritic Cell Vaccines and NK Cells in Adoptive Cell Immunotherapy
Vaccines 2021cited by 40position: lastdoi
Experimental postoperative ileus: is Th2 immune response involved?
International Journal of Medical Sciences 2021cited by 8position: lastdoi
Enhanced expression of CD39 and CD73 on T cells in the regulation of anti-tumor immune responses
OncoImmunology 2020cited by 66position: middledoi
Microbiome Analysis from Paired Mucosal and Fecal Samples of a Colorectal Cancer Biobank
Cancers 2020cited by 22position: middledoi
Establishment of an Endoscopy-Guided Minimally Invasive Orthotopic Mouse Model of Colorectal Cancer
Cancers 2020cited by 11position: middledoi
Retraction Note to: cGMP-phosphodiesterase 6, transducin and Wnt5a/Frizzled-2-signaling control cGMP and Ca2+ homeostasis in melanoma cells
Cellular and Molecular Life Sciences 2020cited by 0position: firstdoi
The role of interleukin-18 in pancreatitis and pancreatic cancer
Cytokine & Growth Factor Reviews 2019cited by 65position: middledoi
Association of differential miRNA expression with hepatic vs. peritoneal metastatic spread in colorectal cancer
BMC Cancer 2018cited by 26position: middledoi
Advances in the Development of Anticancer HSP-based Vaccines
Current Medicinal Chemistry 2018cited by 11position: middledoi
Notch-Induced Myeloid Reprogramming in Spontaneous Pancreatic Ductal Adenocarcinoma by Dual Genetic Targeting
Cancer Research 2018cited by 10position: middledoi
Development of a reliable and accurate algorithm to quantify the tumor immune stroma (QTiS) across tumor types
Oncotarget 2017cited by 23position: lastdoi
Mitochondria and Mitochondrial ROS in Cancer: Novel Targets for Anticancer Therapy
Journal of Cellular Physiology 2016cited by 684position: lastdoi
Characterization of myeloid leukocytes and soluble mediators in pancreatic cancer: importance of myeloid-derived suppressor cells
OncoImmunology 2015cited by 105position: lastdoi
Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer
Oncotarget 2015cited by 72position: middledoi
Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine
Oncotarget 2014cited by 66position: middledoi
Extracellular adenosine metabolism in immune cells in melanoma
Cancer Immunology Immunotherapy 2014cited by 64position: middledoi
Knockdown of lecithin retinol acyltransferase increases all‐<i>trans</i> retinoic acid levels and restores retinoid sensitivity in malignant melanoma cells
Experimental Dermatology 2014cited by 8position: middledoi
Reactive Oxygen Species in the Immune System
International Reviews of Immunology 2013cited by 506position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jens Werner · University Hospital Heidelberg23 papers (2012–2023)Florian Kühn · LMU Klinikum8 papers (2020–2023)Svetlana Karakhanova · Heidelberg University8 papers (2012–2020)Ulrich Wirth · Ludwig-Maximilians-Universität München6 papers (2020–2023)Ivan Shevchenko · German Cancer Research Center6 papers (2012–2020)Yuhui Yang · Jiangsu University5 papers (2013–2022)Dominik Koch · Ludwig-Maximilians-Universität München5 papers (2022–2023)Matthias Ilmer · Mayo Clinic5 papers (2020–2023)Josefine Schardey · Ludwig-Maximilians-Universität München5 papers (2022–2023)Viktor Umansky · University of Mannheim5 papers (2012–2015)Bernhard W. Renz · German Cancer Research Center4 papers (2022–2023)Jan DʼHaese · Apple (Israel)4 papers (2016–2023)Jens Neumann · Hamburg Institute for Therapy Research4 papers (2018–2023)Joachim Andrassy · LMU Klinikum4 papers (2020–2023)Andrey A. Zamyatnin · Harbin Medical University4 papers (2018–2021)Tobias S. Schiergens · LMU Klinikum3 papers (2020–2021)Stefan B. Eichmüller · German Cancer Research Center3 papers (2013–2020)Sabine Soltek · University Hospital Heidelberg3 papers (2012–2013)Markus Guba · Ludwig-Maximilians-Universität München3 papers (2017–2023) · 3 papers (2012–2015)